Loading organizations...
§ Private Profile · Boston, MA, USA
The only R&D data cloud for life sciences
TetraScience has raised $88.5M across 3 funding rounds.
Key people at TetraScience.
TetraScience was founded in 2014 by Siping Wang (Founder/CTO).
TetraScience has raised $88.5M in total across 3 funding rounds.
TetraScience provides the world’s first and only R&D Data Cloud, with a mission to transform life sciences R&D, accelerate discovery, and improve human life. Scientists at global pharma and biotech organizations rely on our innovative Tetra Data Platform for easy access to centralized, harmonized, and actionable scientific data to accelerate their digital lab transformation. With best-in-class SaaS performance, a team of industry innovators, and excellent product/market fit, Tetra is positioned to become an iconic life sciences software company.
TetraScience has raised $88.5M across 3 funding rounds. Most recently, it raised $80.0M Series B in April 2021.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Apr 1, 2021 | $80M Series B | — | Bain Capital Ventures, Bond, General Catalyst, Insight Partners, LETA Capital, Marcus Bartram | Announced |
| Oct 1, 2019 | $8M Series A | — | Founder Collective, Pillar VC, First Round Capital, Floodgate, Underscore VC, Waters Corporation, Y Combinator | Announced |
| Aug 14, 2015 | $500K Venture Round | — | — | Announced |
Key people at TetraScience.
TetraScience was founded in 2014 by Siping Wang (Founder/CTO).
TetraScience has raised $88.5M in total across 3 funding rounds.
TetraScience's investors include Bain Capital Ventures, Bond, General Catalyst, Insight Partners, Leta Capital, Marcus Bartram, Founder Collective, Pillar VC, First Round Capital, Floodgate, Underscore VC, Waters Corporation.
TetraScience is a pioneering company that offers the world’s first and only R&D Data Cloud specifically designed for life sciences. Its mission is to transform life sciences research and development (R&D), accelerate scientific discovery, and ultimately improve and extend human life. The company builds the Tetra Data Platform (TDP), a cloud-native, AI-enabled platform that centralizes, harmonizes, and makes scientific data actionable for global pharmaceutical and biotech organizations. This platform addresses the challenge of fragmented and siloed data in traditional lab environments by enabling seamless integration across lab instruments, informatics applications, and analytics tools, thus accelerating digital lab transformation and scientific innovation[1][2][3].
Founded in 2015 by Siping Wang, who serves as Founder and CTO, TetraScience emerged from the recognition that scientific data in life sciences is trapped in millions of silos and proprietary formats, limiting the potential of AI-driven insights. The company’s early traction was marked by its unique approach to creating an open, vendor-agnostic scientific data stack that liberates and future-proofs customers’ data. This approach has positioned TetraScience as a leader in the scientific AI revolution, with a growing suite of next-generation lab data management products and a large integration network that includes lab instruments, CROs, analytics, and data science partners[1][2][4].
TetraScience rides the growing trend of digital transformation and AI adoption in life sciences R&D. The timing is critical as the industry faces increasing pressure to accelerate drug discovery and development while managing vast, complex data sets. Market forces such as the rise of cloud computing, AI/ML capabilities, and the need for interoperability among diverse scientific instruments and software systems favor TetraScience’s platform. By enabling a vendor-agnostic, data-centric approach, TetraScience influences the broader ecosystem by setting new standards for scientific data management and AI-driven innovation in life sciences[4][7].
Looking ahead, TetraScience is poised to expand its influence by deepening AI integration and broadening its platform capabilities to cover more scientific use cases and workflows. Trends such as increased adoption of AI in drug discovery, personalized medicine, and collaborative research networks will shape its journey. The company’s commitment to radical transparency, scientific rigor, and customer success suggests it will continue to be a key enabler of the scientific AI revolution, helping life sciences organizations unlock the full potential of their data to accelerate breakthroughs and improve human health[2][4][5]. This aligns with its founding mission to transform life sciences R&D and improve human life through innovative data solutions.
